Find more articles

Positron Emission Tomography (PET)

Dr. Eric Turcotte,

Positron Emission Tomography (PET) is a cutting edge, non-invasive, diagnostic imaging technique which allows the measurement of biochemical processes or the expression of cellular receptors by the use of positron-emitting radioactive tracers. The imaging tracers most often contain atoms naturally found in organic molecules, but in the form of radioactive analogues of Oxygen (15O), Nitrogen […]

Read article

THERAGNOSTICS- Lu-177-PSMA treatment for metastatic prostate cancer – case examples

Dr. Kalevi Kairemo,

Prostate specific membrane antigen (PSMA) is a membrane glycoprotein with enzymatic activity (as explained in vol.1 no.2. by Jean-Luc Urbain). It is highly expressed in high-risk prostate cancer and therefore PSMA could be a basis for theragnostics. 177Lu-PSMA radioligand therapy is mainly used for patients with end-stage prostate cancer, but it can be used earlier. […]

Read article

THERANOSTICS – The merging of drug therapy and diagnostics to advance personalised medicine

Dr. Jean Luc Urbain,

M.D., Ph.D., CPE, President of the WFNMB

INTRODUCTION: In the second issue of our magazine we described the therapeutic use of Iodine, the first true Theranostics compound available. In this edition of our magazine we will put the emphasis on the most recent developments in the utilization of medical isotopes for therapy of cancers.   The modern landmark for Theranostic nuclear medicine […]

Read article

Nuclear Brain Imaging In Medical Practice In Japan

Dr. Jun Hatazawa,

Dr. Jun Hatazawa , MD, PhD

Dr. Jun Hatazawa, M.D., Ph.D., President of the AOFNMB, Japan BASIS OF NUCLEAR BRAIN IMAGING Brain is an organ by which we can perceive, exercise, learn, remember, think, behave and imagine among other tasks. To fulfill its functions, the brain exclusively metabolizes glucose to produce energy in the form of adenosine triphosphate (ATP) by oxidative […]

Read article

Theranostics

Dr. Olfat Kamel Hasan,

Dr. Kamel Hasan, Olfat, MBChB, FRCR, FRCPC Nuclear Medicine and Molecular Imaging Physician Hamilton Health Sciences and St. Joseph’s Healthcare McMaster University Ontario, Canada INTRODUCTION Over the past 30 years, there have been colossal advances in the way we have lived life through the development and innovation of scientists worldwide. From the creation of the […]

Read article

FRACTURES A DIFFERENT APPROACH: THE ROLE OF EARLY BONE SCANNING

Dr Christopher O’Brien MDCM; FRCPC,

Christopher O’Brien MDCM; FRCPC Medical Director, Nuclear Medicine Brantford General Hospital Ontario, Canada FRACTURES A DIFFERENT APPROACH: THE ROLE OF EARLY BONE SCANNING The three-phase bone scan is a very sensitive technique used in the detection of fractures of any cause. The sensitivity can be further increased through the use of SPECT and the specificity can be […]

Read article

Interview, James McBrayer, CEO of Cyclopharma LTD

Dr. Francois Lamoureux,

M.D, M.Sc., FRCP(C), ABNM, president of the CANM-ACMN

James McBrayer CEO, Cyclopharm Ltd www.cyclopharm.com You have been actively involved in the field of nuclear medicine for quite a while. Looking back at your career, what are the most significant changes that you have witnessed in the field over the past 10 years? I have witnessed a great deal of change since starting in […]

Read article

Interview with Tom Francke, CEO Hermes Medical Solutions

Dr. Francois Lamoureux,

M.D, M.Sc., FRCP(C), ABNM, president of the CANM-ACMN

Tom Francke CEO Hermes Medical Solutions Where do you see Nuclear Medicine and Molecular Imaging heading to, and what is your, respectively Hermes Medical Solutions contribution to it? I strongly believe in Theranostics. We see new therapies being developed almost quarterly, and an ever-growing support of these therapies by molecular imaging. Not only for port- […]

Read article

Interview with Heather Chalmers, President and Chief Executive Officer for GE Canada

Dr. Francois Lamoureux,

M.D, M.Sc., FRCP(C), ABNM, president of the CANM-ACMN

You are the President and CEO, GE Canada; President, GE Healthcare Canada. Could you give us a little glimpse of your background before becoming the President and CEO? First, it is my pleasure and honour to be part of the discussion today. Nuclear medicine is critical to the efficacy of our healthcare systems in Canada […]

Read article

Terapia con yodo – 131 (yodo radioactivo) en Hipertiroidismo

Dr. Juan Luis Londono,

Médico Nuclear Jefe servicio Medicina Nuclear San Vicente Fundación Hospital Universitario, Columbia

La tiroides es la glándula endocrina más grande de nuestro cuerpo y cumple funciones muy importantes, como la producción de hormonas tiroideas.    Se necesita que haya niveles de hormonas tiroideas normales para que exista un funcionamiento de todos los tejidos y órganos en el cuerpo. Se estima que existe cerca de un 11% de la […]

Read article